304 related articles for article (PubMed ID: 26288987)
1. Predictive models for lymph node metastases in patients with testicular germ cell tumors.
Mao Y; Hedgire S; Prapruttam D; Harisinghani M
Abdom Imaging; 2015 Oct; 40(8):3196-205. PubMed ID: 26288987
[TBL] [Abstract][Full Text] [Related]
2. Radiomics allows for detection of benign and malignant histopathology in patients with metastatic testicular germ cell tumors prior to post-chemotherapy retroperitoneal lymph node dissection.
Baessler B; Nestler T; Pinto Dos Santos D; Paffenholz P; Zeuch V; Pfister D; Maintz D; Heidenreich A
Eur Radiol; 2020 Apr; 30(4):2334-2345. PubMed ID: 31828413
[TBL] [Abstract][Full Text] [Related]
3. Detection of retroperitoneal metastases in early-stage nonseminomatous testicular cancer: analysis of different CT criteria.
Stomper PC; Fung CY; Socinski MA; Jochelson MS; Garnick MB; Richie JP
AJR Am J Roentgenol; 1987 Dec; 149(6):1187-90. PubMed ID: 2825494
[TBL] [Abstract][Full Text] [Related]
4. Craniocaudal retroperitoneal node length as a risk factor for relapse from clinical stage I testicular germ cell tumor.
Howard SA; Gray KP; O'Donnell EK; Fennessy FM; Beard CJ; Sweeney CJ
AJR Am J Roentgenol; 2014 Oct; 203(4):W415-20. PubMed ID: 25247970
[TBL] [Abstract][Full Text] [Related]
5. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
Beck SD; Foster RS; Bihrle R; Donohue JP
Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
7. [Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
Müller-Mattheis V; Reinhardt M; Gerharz CD; Fürst G; Vosberg H; Müller-Gärtner HW; Ackermann R
Urologe A; 1998 Nov; 37(6):609-20. PubMed ID: 9887489
[TBL] [Abstract][Full Text] [Related]
8. CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria.
Hilton S; Herr HW; Teitcher JB; Begg CB; Castéllino RA
AJR Am J Roentgenol; 1997 Aug; 169(2):521-5. PubMed ID: 9242768
[TBL] [Abstract][Full Text] [Related]
9. Correlation between retroperitoneal lymph node size and presence of metastases in nonseminomatous germ cell tumors.
Hudolin T; Kastelan Z; Knezevic N; Goluza E; Tomas D; Coric M
Int J Surg Pathol; 2012 Feb; 20(1):15-8. PubMed ID: 22180527
[TBL] [Abstract][Full Text] [Related]
10. Lymph node density in retroperitoneal lymph node dissection as a novel marker for predicting recurrence in patients with germ cell testicular cancer: A case-control study and long-term clinical experience of a tertiary referral hospital.
Sarikaya S; Karsiyakali N; Kaya E; Topuz B; Ebiloglu T; Zor M
Actas Urol Esp (Engl Ed); 2021; 45(1):30-38. PubMed ID: 33010987
[TBL] [Abstract][Full Text] [Related]
11. Risk stratification of pubertal children and postpubertal adolescents with clinical stage I testicular nonseminomatous germ cell tumors.
Cost NG; Lubahn JD; Adibi M; Romman A; Wickiser JE; Raj GV; Sagalowsky AI; Margulis V
J Urol; 2014 May; 191(5 Suppl):1485-90. PubMed ID: 24679874
[TBL] [Abstract][Full Text] [Related]
12. [Inguinal lymphatic metastasis of cancer of the testis: staging and therapeutic approach].
Mianné DM; Barnaud P; Altobelli A; Masson J; Valeri A
Ann Urol (Paris); 1991; 25(4):199-202. PubMed ID: 1660694
[TBL] [Abstract][Full Text] [Related]
13. Microvascular invasion of testicular nonseminomatous germ cell tumors: implications of separate evaluation of lymphatic and blood vessels.
Heinzelbecker J; Gross-Weege M; Weiss C; Hörner C; Trunk MJ; Erben P; Haecker A; Bolenz C
J Urol; 2014 Aug; 192(2):593-9. PubMed ID: 24631105
[TBL] [Abstract][Full Text] [Related]
14. [Clinical presentation of testicular germinal cancer].
Fernández Gómez JM; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; Escaf Barmadah S; García Rodríguez J; Pérez García FJ; Rodríguez Faba O; Jalón Monzón A
Arch Esp Urol; 2002 Oct; 55(8):915-22. PubMed ID: 12455282
[TBL] [Abstract][Full Text] [Related]
15. Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters?
Spiess PE; Brown GA; Pisters LL; Liu P; Tu SM; Evans JG; Kamat AM; Black P; Tannir NM
Cancer; 2006 Oct; 107(7):1503-10. PubMed ID: 16944534
[TBL] [Abstract][Full Text] [Related]
16. Improved accuracy of computerized tomography based clinical staging in low stage nonseminomatous germ cell cancer using size criteria of retroperitoneal lymph nodes.
Leibovitch L; Foster RS; Kopecky KK; Donohue JP
J Urol; 1995 Nov; 154(5):1759-63. PubMed ID: 7563341
[TBL] [Abstract][Full Text] [Related]
17. What is the role of enlarged lymph node resection alone in patients with nonseminomatous germ cell tumor who had stage II or III disease?
Ekenel M; Keskin S; Sanli Ö; Bavbek S; Tunç M; Ander H; Ozcan F; Kiliçaslan I; Başaran M
Clin Genitourin Cancer; 2012 Sep; 10(3):185-9. PubMed ID: 22682983
[TBL] [Abstract][Full Text] [Related]
18. Inguinal lymph node metastases from testicular tumor.
Stein M; Steiner M; Suprun H; Robinson E
J Urol; 1985 Jul; 134(1):144-5. PubMed ID: 2989564
[TBL] [Abstract][Full Text] [Related]
19. Vascular invasion as a prognosticator of metastatic disease in nonseminomatous germ cell tumors of the testis. Importance in "surveillance only" protocols.
Moriyama N; Daly JJ; Keating MA; Lin CW; Prout GR
Cancer; 1985 Nov; 56(10):2492-8. PubMed ID: 2412688
[TBL] [Abstract][Full Text] [Related]
20. A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only.
Nicolai N; Miceli R; Artusi R; Piva L; Pizzocaro G; Salvioni R
J Urol; 2004 Jan; 171(1):172-6. PubMed ID: 14665870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]